On Demand: Navigating the 2026 CV Reimbursement Landscape: Strategies for Financial Sustainability and Program Growth-Webinar Recording

Video Transcription

Video Summary

MedAxium and United Imaging hosted a panel on navigating the 2026 cardiovascular reimbursement landscape. The discussion focused on how recent CMS reimbursement improvements for cardiac CT, along with the 2021 chest pain guidelines, have boosted adoption of CCTA and made advanced cardiovascular imaging more financially viable. Panelists emphasized that cardiac CT is increasingly seen as a class 1, high-value tool for diagnosing coronary disease, reducing unnecessary catheterizations, and improving outcomes.<br /><br />They also discussed operational pressures such as workforce shortages, technician training, workflow optimization, and the need for scalable processes. J.D. Enright stressed “technology, personnel, and process optimization,” while Drs. Osborne and Ayala highlighted the importance of skilled technologists and modern scanners with faster rotation and better resolution.<br /><br />A major theme was the role of AI and integrated imaging platforms. The panel warned that fragmented AI subscriptions can create operational complexity and argued for end-to-end solutions that combine imaging, physiology, plaque analysis, and clinical follow-through. They concluded that success will depend on proving value through measurable outcomes, patient satisfaction, reduced unnecessary procedures, and improved long-term cardiovascular care.

Keywords

cardiovascular reimbursement

cardiac CT

CCTA adoption

CMS reimbursement

2021 chest pain guidelines

workflow optimization

AI imaging platforms

coronary disease diagnosis

cardiovascular outcomes